Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Related Articles by Review for PubMed (Select 12594648)

1.

Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa.

Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA.

Clin Infect Dis. 2003 Mar 1;36(5):652-62. Epub 2003 Feb 17. Review.

2.
3.

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2004 [correction].

Berenguer J, Laguna F, López-Aldeguer J, Moreno S, Arribas JR, Arrizabalaga J, Baraia J, Casado JL, Cosín J, Polo R, González-García J, Iribarren JA, Kindelán JM, López-Bernaldo de Quirós JC, López-Vélez R, Lorenzo JF, Lozano F, Mallolas J, Miró JM, Pulido F, Ribera E.

Enferm Infecc Microbiol Clin. 2004 Mar;22(3):160-76. Review. English, Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2004 Nov;22(5):271.

PMID:
14987537
4.

HIV and co-infections.

Chang CC, Crane M, Zhou J, Mina M, Post JJ, Cameron BA, Lloyd AR, Jaworowski A, French MA, Lewin SR.

Immunol Rev. 2013 Jul;254(1):114-42. doi: 10.1111/imr.12063. Review.

5.

Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.

Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM.

Am J Trop Med Hyg. 1996 Jul;55(1):1-11. Review.

PMID:
8702012
6.

Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa.

Korenromp EL, Williams BG, de Vlas SJ, Gouws E, Gilks CF, Ghys PD, Nahlen BL.

Emerg Infect Dis. 2005 Sep;11(9):1410-9. Review.

7.
8.

Clinical trials in sub-Saharan Africa and established standards of care: a systematic review of HIV, tuberculosis, and malaria trials.

Kent DM, Mwamburi DM, Bennish ML, Kupelnick B, Ioannidis JP.

JAMA. 2004 Jul 14;292(2):237-42. Review.

PMID:
15249573
9.

Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.

Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R.

AIDS. 2012 Nov 13;26(17):2121-33. doi: 10.1097/QAD.0b013e3283565dd1. Review.

10.

NeuroAIDS in sub-Saharan Africa: a clinical review.

Alkali NH, Bwala SA, Nyandaiti YW, Danesi MA.

Ann Afr Med. 2013 Jan-Mar;12(1):1-10. doi: 10.4103/1596-3519.108242. Review.

11.

Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation.

Burnett RJ, François G, Kew MC, Leroux-Roels G, Meheus A, Hoosen AA, Mphahlele MJ.

Liver Int. 2005 Apr;25(2):201-13. Review.

PMID:
15780040
12.

[Pulmonary complications of human immunodeficiency virus infection in sub-Saharan Africa].

Domoua K, N'Dhatz M, Coulibaly G, Traoré F, Koffi J, Achi V, Cissé L, Kouamé S, Beugré LK, Konan JB, Yapi A.

Rev Pneumol Clin. 1997;53(2):79-84. Review. French.

PMID:
9205686
13.

Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies.

Maher D, Harries A, Getahun H.

Trop Med Int Health. 2005 Aug;10(8):734-42. Review.

14.

Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1.

Harries AD, Hargreaves NJ, Kemp J, Jindani A, Enarson DA, Maher D, Salaniponi FM.

Lancet. 2001 May 12;357(9267):1519-23. Review. No abstract available.

PMID:
11377627
15.

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.

Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, Sterling TR, Chaisson RE, Williams BG, Harries AD, Granich RM.

PLoS Med. 2012;9(7):e1001270. doi: 10.1371/journal.pmed.1001270. Epub 2012 Jul 24. Review.

16.

Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.

Peterson K, van Griensven J, Huis in 't Veld D, Colebunders R.

Expert Rev Anti Infect Ther. 2012 Jan;10(1):43-50. doi: 10.1586/eri.11.151. Review.

PMID:
22149613
17.

AIDS in Africa.

O'Keefe EA, Wood R.

Scand J Gastroenterol Suppl. 1996;220:147-52. Review.

PMID:
8898454
18.

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment.

Corbett EL, Marston B, Churchyard GJ, De Cock KM.

Lancet. 2006 Mar 18;367(9514):926-37. Review.

PMID:
16546541
19.

Prevention of HIV-associated opportunistic infections and diseases in the age of highly active antiretroviral therapy.

Willemot P, Klein MB.

Expert Rev Anti Infect Ther. 2004 Aug;2(4):521-32. Review.

PMID:
15482218
20.

Chemoprophylaxis for tuberculosis in HIV-infected individuals in sub-Saharan Africa.

Nuwaha F.

East Afr Med J. 1998 Sep;75(9):520-7. Review.

PMID:
10493054
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk